Lexaria Bioscience Corp (NASDAQ: LEXX) has announced the signing of an advertising and media agreement for digital marketing and media buys with SRAX Inc. CEO of...
Lexaria Bioscience Corp (NASDAQ: LEXX) announced an expansion of its intellectual property portfolio. The news comes after the global innovator in drug delivery platforms was granted...
Lexaria Bioscience Corp (OTCMKTS:LEXX) announced its effectiveness in its DehydraTECHTM technology, which is outstanding in testing antiviral drugs. It wants to lead in the fight against...